High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion

HFNC seems to increase droplet spread, so caution should be taken if it is applied for COVID-19, and adequate protective measures should be provided. Further research on viral spread and risks associated with HFNC therapy in COVID-19 patients is needed. https://bit.ly/3gQjjrY

Detalles Bibliográficos
Autores principales: Elshof, Judith, Hebbink, Rutger H.J., Duiverman, Marieke L., Hagmeijer, Rob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453729/
https://www.ncbi.nlm.nih.gov/pubmed/32859674
http://dx.doi.org/10.1183/13993003.03004-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453729/
https://www.ncbi.nlm.nih.gov/pubmed/32859674
http://dx.doi.org/10.1183/13993003.03004-2020

Ejemplares similares